| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9312767 | Urology | 2005 | 5 Pages |
Abstract
Whether patients with traditionally low-risk but large MTD prostate cancer fare better when treated with adjuvant radiotherapy compared with salvage radiotherapy remains to be answered in the setting of a randomized trial.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Tomas Dvorak, Ming-Hui Chen, Andrew A. Renshaw, Marian Loffredo, Jerome P. Richie, Anthony V. D'Amico,